Earnings Feed
Start Free
Synergy CHC Corp.·4

Jul 1, 4:40 PM ET

Baumeler Alfred 4

Research Summary

AI-generated summary

Updated

Synergy CHC (SNYR) President Alfred Baumeler Receives Modified Option Grant

What Happened

  • Alfred Baumeler, President and a director of Synergy CHC Corp. (SNYR), had a 150,000-share option cancelled and was granted a new 150,000-share option on June 29, 2026. Both entries are reported as derivative transactions (no per-share price shown in the filing).
  • The filing notes the change reflects a reduction in the exercise price of the original option, which the company treats as a material modification — effectively cancelling the original option and issuing a replacement option with the same vesting schedule.

Key Details

  • Transaction date: June 29, 2026; Form 4 filed July 1, 2026 (covering the June 29 transactions).
  • Reported transactions: Disposition to issuer (cancellation) of 150,000 derivative shares and simultaneous acquisition (new grant) of 150,000 derivative shares. Price: N/A (not reported).
  • Vesting: One-third vests on the first anniversary of the original grant date (Sept 18, 2025); remaining two-thirds vest in equal monthly installments over the following 24 months (see footnote). The new option vests as if granted on the original grant date.
  • Expiration: The new option expires on the five-year anniversary of the original grant date (Sept 18, 2030).
  • Shares owned after transaction: Not specified in the Form 4.
  • Footnotes: F1 describes the vesting schedule. F2 explains the exercise-price reduction constitutes a material modification and the original option is deemed cancelled and replaced.
  • Filing timeliness: Form 4 was filed on July 1, 2026 for transactions dated June 29, 2026 (no late-filing flag reported).

Context

  • This filing reflects an option modification (derivative transaction), not an open-market buy or sell of stock. Such modifications can change the option's economics (here, a reduced exercise price), but do not by themselves indicate buying or selling of underlying shares.
  • For retail investors, option grants/modifications by insiders are informative about compensation and retention, but they don't directly imply immediate market purchases or sales.